Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest

Wu et al., Molecular Therapy, doi:10.1016/j.ymthe.2022.12.002
Dec 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.002 from 12 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Mouse study showing quercetin can significantly inhibit SARS-CoV-2 induced acute kidney injury via blocking of SARS-CoV-2 N-Smad3-mediated cell death.
Bioavailability. Quercetin has low bioavailability and studies typically use advanced formulations to improve bioavailability which may be required to reach therapeutic concentrations.
73 preclinical studies support the efficacy of quercetin for COVID-19:
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spikeA,3,9,10,22,24,25,30,38,39,41,42,62-64, MproB,3,7,9,11,13,15,17,18,20,23,24,30,34,36-38,42,43,45,63-65, RNA-dependent RNA polymeraseC,1,3,9,32,64, PLproD,3,37,45, ACE2E,22,23,28,37,41,63, TMPRSS2F,22, nucleocapsidG,3, helicaseH,3,29,34, endoribonucleaseI,39, NSP16/10J,6, cathepsin LK,26, Wnt-3L,22, FZDM,22, LRP6N,22, ezrinO,40, ADRPP,38, NRP1Q,41, EP300R,16, PTGS2S,23, HSP90AA1T,16,23, matrix metalloproteinase 9U,31, IL-6V,21,35, IL-10W,21, VEGFAX,35, and RELAY,35 proteins. In Vitro studies demonstrate inhibition of the MproB,15,46,51,59 protein, and inhibition of spike-ACE2 interactionZ,47. In Vitro studies demonstrate efficacy in Calu-3AA,50, A549AB,21, HEK293-ACE2+AC,58, Huh-7AD,25, Caco-2AE,49, Vero E6AF,19,42,49, mTECAG,52, and RAW264.7AH,52 cells. Animal studies demonstrate efficacy in K18-hACE2 miceAI,55, db/db miceAJ,52,61, BALB/c miceAK,60, and rats66. Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice60, inhibits LPS-induced cytokine storm by modulating key inflammatory and antioxidant pathways in macrophages5, and inhibits SARS-CoV-2 ORF3a ion channel activity, which contributes to viral pathogenicity and cytotoxicity54.
a. The trimeric spike (S) protein is a glycoprotein that mediates viral entry by binding to the host ACE2 receptor, is critical for SARS-CoV-2's ability to infect host cells, and is a target of neutralizing antibodies. Inhibition of the spike protein prevents viral attachment, halting infection at the earliest stage.
b. The main protease or Mpro, also known as 3CLpro or nsp5, is a cysteine protease that cleaves viral polyproteins into functional units needed for replication. Inhibiting Mpro disrupts the SARS-CoV-2 lifecycle within the host cell, preventing the creation of new copies.
c. RNA-dependent RNA polymerase (RdRp), also called nsp12, is the core enzyme of the viral replicase-transcriptase complex that copies the positive-sense viral RNA genome into negative-sense templates for progeny RNA synthesis. Inhibiting RdRp blocks viral genome replication and transcription.
d. The papain-like protease (PLpro) has multiple functions including cleaving viral polyproteins and suppressing the host immune response by deubiquitination and deISGylation of host proteins. Inhibiting PLpro may block viral replication and help restore normal immune responses.
e. The angiotensin converting enzyme 2 (ACE2) protein is a host cell transmembrane protein that serves as the cellular receptor for the SARS-CoV-2 spike protein. ACE2 is expressed on many cell types, including epithelial cells in the lungs, and allows the virus to enter and infect host cells. Inhibition may affect ACE2's physiological function in blood pressure control.
f. Transmembrane protease serine 2 (TMPRSS2) is a host cell protease that primes the spike protein, facilitating cellular entry. TMPRSS2 activity helps enable cleavage of the spike protein required for membrane fusion and virus entry. Inhibition may especially protect respiratory epithelial cells, buy may have physiological effects.
g. The nucleocapsid (N) protein binds and encapsulates the viral genome by coating the viral RNA. N enables formation and release of infectious virions and plays additional roles in viral replication and pathogenesis. N is also an immunodominant antigen used in diagnostic assays.
h. The helicase, or nsp13, protein unwinds the double-stranded viral RNA, a crucial step in replication and transcription. Inhibition may prevent viral genome replication and the creation of new virus components.
i. The endoribonuclease, also known as NendoU or nsp15, cleaves specific sequences in viral RNA which may help the virus evade detection by the host immune system. Inhibition may hinder the virus's ability to mask itself from the immune system, facilitating a stronger immune response.
j. The NSP16/10 complex consists of non-structural proteins 16 and 10, forming a 2'-O-methyltransferase that modifies the viral RNA cap structure. This modification helps the virus evade host immune detection by mimicking host mRNA, making NSP16/10 a promising antiviral target.
k. Cathepsin L is a host lysosomal cysteine protease that can prime the spike protein through an alternative pathway when TMPRSS2 is unavailable. Dual targeting of cathepsin L and TMPRSS2 may maximize disruption of alternative pathways for virus entry.
l. Wingless-related integration site (Wnt) ligand 3 is a host signaling molecule that activates the Wnt signaling pathway, which is important in development, cell growth, and tissue repair. Some studies suggest that SARS-CoV-2 infection may interfere with the Wnt signaling pathway, and that Wnt3a is involved in SARS-CoV-2 entry.
m. The frizzled (FZD) receptor is a host transmembrane receptor that binds Wnt ligands, initiating the Wnt signaling cascade. FZD serves as a co-receptor, along with ACE2, in some proposed mechanisms of SARS-CoV-2 infection. The virus may take advantage of this pathway as an alternative entry route.
n. Low-density lipoprotein receptor-related protein 6 is a cell surface co-receptor essential for Wnt signaling. LRP6 acts in tandem with FZD for signal transduction and has been discussed as a potential co-receptor for SARS-CoV-2 entry.
o. The ezrin protein links the cell membrane to the cytoskeleton (the cell's internal support structure) and plays a role in cell shape, movement, adhesion, and signaling. Drugs that occupy the same spot on ezrin where the viral spike protein would bind may hindering viral attachment, and drug binding could further stabilize ezrin, strengthening its potential natural capacity to impede viral fusion and entry.
p. The Adipocyte Differentiation-Related Protein (ADRP, also known as Perilipin 2 or PLIN2) is a lipid droplet protein regulating the storage and breakdown of fats in cells. SARS-CoV-2 may hijack the lipid handling machinery of host cells and ADRP may play a role in this process. Disrupting ADRP's interaction with the virus may hinder the virus's ability to use lipids for replication and assembly.
q. Neuropilin-1 (NRP1) is a cell surface receptor with roles in blood vessel development, nerve cell guidance, and immune responses. NRP1 may function as a co-receptor for SARS-CoV-2, facilitating viral entry into cells. Blocking NRP1 may disrupt an alternative route of viral entry.
r. EP300 (E1A Binding Protein P300) is a transcriptional coactivator involved in several cellular processes, including growth, differentiation, and apoptosis, through its acetyltransferase activity that modifies histones and non-histone proteins. EP300 facilitates viral entry into cells and upregulates inflammatory cytokine production.
s. Prostaglandin G/H synthase 2 (PTGS2, also known as COX-2) is an enzyme crucial for the production of inflammatory molecules called prostaglandins. PTGS2 plays a role in the inflammatory response that can become severe in COVID-19 and inhibitors (like some NSAIDs) may have benefits in dampening harmful inflammation, but note that prostaglandins have diverse physiological functions.
t. Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1) is a chaperone protein that helps other proteins fold correctly and maintains their stability. HSP90AA1 plays roles in cell signaling, survival, and immune responses. HSP90AA1 may interact with numerous viral proteins, but note that it has diverse physiological functions.
u. Matrix metalloproteinase 9 (MMP9), also called gelatinase B, is a zinc-dependent enzyme that breaks down collagen and other components of the extracellular matrix. MMP9 levels increase in severe COVID-19. Overactive MMP9 can damage lung tissue and worsen inflammation. Inhibition of MMP9 may prevent excessive tissue damage and help regulate the inflammatory response.
v. The interleukin-6 (IL-6) pro-inflammatory cytokine (signaling molecule) has a complex role in the immune response and may trigger and perpetuate inflammation. Elevated IL-6 levels are associated with severe COVID-19 cases and cytokine storm. Anti-IL-6 therapies may be beneficial in reducing excessive inflammation in severe COVID-19 cases.
w. The interleukin-10 (IL-10) anti-inflammatory cytokine helps regulate and dampen immune responses, preventing excessive inflammation. IL-10 levels can also be elevated in severe COVID-19. IL-10 could either help control harmful inflammation or potentially contribute to immune suppression.
x. Vascular Endothelial Growth Factor A (VEGFA) promotes the growth of new blood vessels (angiogenesis) and has roles in inflammation and immune responses. VEGFA may contribute to blood vessel leakiness and excessive inflammation associated with severe COVID-19.
y. RELA is a transcription factor subunit of NF-kB and is a key regulator of inflammation, driving pro-inflammatory gene expression. SARS-CoV-2 may hijack and modulate NF-kB pathways.
z. The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor is a primary method of viral entry, inhibiting this interaction can prevent the virus from attaching to and entering host cells, halting infection at an early stage.
aa. Calu-3 is a human lung adenocarcinoma cell line with moderate ACE2 and TMPRSS2 expression and SARS-CoV-2 susceptibility. It provides a model of the human respiratory epithelium, but many not be ideal for modeling early stages of infection due to the moderate expression levels of ACE2 and TMPRSS2.
ab. A549 is a human lung carcinoma cell line with low ACE2 expression and SARS-CoV-2 susceptibility. Viral entry/replication can be studied but the cells may not replicate all aspects of lung infection.
ac. HEK293-ACE2+ is a human embryonic kidney cell line engineered for high ACE2 expression and SARS-CoV-2 susceptibility.
ad. Huh-7 cells were derived from a liver tumor (hepatoma).
ae. Caco-2 cells come from a colorectal adenocarcinoma (cancer). They are valued for their ability to form a polarized cell layer with properties similar to the intestinal lining.
af. Vero E6 is an African green monkey kidney cell line with low/no ACE2 expression and high SARS-CoV-2 susceptibility. The cell line is easy to maintain and supports robust viral replication, however the monkey origin may not accurately represent human responses.
ag. mTEC is a mouse tubular epithelial cell line.
ah. RAW264.7 is a mouse macrophage cell line.
ai. A mouse model expressing the human ACE2 receptor under the control of the K18 promoter.
aj. A mouse model of obesity and severe insulin resistance leading to type 2 diabetes due to a mutation in the leptin receptor gene that impairs satiety signaling.
ak. A mouse model commonly used in infectious disease and cancer research due to higher immune response and susceptibility to infection.
Wu et al., 12 Dec 2022, China, peer-reviewed, 9 authors. Contact: hylan@cuhk.edu.hk, yuxueqing@gdph.org.cn, wangxiao773@hotmail.com.
This PaperQuercetinAll
Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest
Wenjing Wu, Wenbiao Wang, Liying Liang, Junzhe Chen, Biao Wei, Xiao-Ru Huang, Professor Xiaoqin Wang, Xueqing Yu, Professor Hui-Yao Lan
Molecular Therapy, doi:10.1016/j.ymthe.2022.12.002
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Author contributions W.W. and W.B. performed the experiment, analyzed the data, and wrote the manuscript; L.L., J.C., B.W. and X.R.H. prepared the animal model and analyzed data; X.W. and X.Y. supervised experiments; H.Y.L. designed, supervised the experiments, and revised the manuscript. Declaration of interests All the authors declared no competing interests.
References
Andrade, Rodrigues, Gomes, Noronha, Acute Kidney Injury as a Condition of Renal Senescence, Cell Transplant
Bulow Anderberg, Luther, Berglund, Larsson, Rubertsson et al., n a l P r e -p r o o f
Caceres, Savickas, Murray, Umanath, Uduman et al., High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome, J Am Soc Nephrol
Carlson, Hsu, Conboy, Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells, Nature
Chan, Chaudhary, Saha, Chauhan, Vaid et al., AKI in Hospitalized Patients with COVID-19, J Am Soc Nephrol
Chen, A potential treatment of COVID-19 with TGF-β blockade, Int J Biol Sci
Chen, Guan, Qiu, Xu, Bai et al., SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl(-) accumulation in respiratory epithelium, Signal Transduct Target Ther
Chen, Wang, Tang, Huang, Yu et al., Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury, Int J Biol Sci
Chen, Wu, Wang, Tang, Lan, Role of TGF-β Signaling in Coronavirus Disease 2019, Integr Med Nephrol Androl
Cheng, Luo, Wang, Zhang, Wang et al., Kidney disease is associated with in-hospital death of patients with COVID-19, Kidney Int
Derosa, Maffioli, D'angelo, Di Pierro, A role for quercetin in coronavirus disease 2019 (COVID-19), Phytother Res
Di Pierro, Derosa, Maffioli, Bertuccioli, Togni et al., Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study, Int J Gen Med
Di Pierro, Iqtadar, Khan, Ullah Mumtaz, Masud Chaudhry et al., Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial, Int J Gen Med
Diao, Wang, Wang, Feng, Zhang et al., Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection, Nat Commun
Ferreira-Gomes, Kruglov, Durek, Heinrich, Tizian et al., SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself, Nat Commun
Fu, Tang, Huang, Feng, Xu et al., Smad7 protects against acute kidney injury by rescuing tubular epithelial cells from the G1 cell cycle arrest, Clin Sci (Lond)
Gao, Gao, Liu, Nie, Sun et al., Identification and functional analysis of the SARS-COV-2 nucleocapsid protein, BMC Microbiol
Gao, He, Liang, Liu, Liu et al., Quercetin ameliorates podocyte injury via inhibition of oxidative stress and the TGF-β1/Smad pathway in DN rats, RSC Adv
Ghazavi, Ganji, Keshavarzian, Rabiemajd, Mosayebi, Cytokine profile and disease severity in patients with COVID-19, Cytokine
Gradin, Andersson, Luther, Anderberg, Rubertsson et al., Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients, Cytokine
Gu, Peng, Lin, Qin, Liang et al., P16(INK4a) played a critical role in exacerbating acute tubular necrosis in acute kidney injury, Am J Transl Res
Gu, Zhang, Cen, Wu, Lu et al., Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study, PLoS One
Gupta, Coca, Chan, Melamed, Brenner et al., AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19, J Am Soc Nephrol
Hamidi, Kadamboor, Veethil, Hamidi, Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective, Pharmacol Rep
He, Wei, Liu, Yi, Liu et al., AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms, Kidney Int
Huang, Bai, He, Xie, Zhou, Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19), Pharmacol Res
Huntington, Carlsen, So, Piesche, Liang et al., Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro
J O U R, n a l P r e -p r o o f Smad3-dependent cell cycle arrest at the G1 phase. (A) Co-IP detects that quercetin dosedependently inhibits the interaction between Flag-N and HA-Smad3 in HEK293T cells coexpressing Flag-SARS-CoV-2 N and HA-Smad3; (B) Western blotting detects that like a Smad3 inhibitor SIS3, pre-treatment with quercetin (64μM) for 24hr is able to inhibit SARS-CoV-2 N protein induced Smad3 signaling in HK-2 cells under high AGE(50µg/ml, 30 mins) conditions ; (C) Western blotting reveals that like a Smad3 inhibitor SIS3, pre-treatment with quercetin (64μM) for 24hr is able to inhibit SARS-CoV-2 N protein induced p-Smad3 nuclear translocation in HK-2 cells under high AGE(50µg/ml, 2hr) conditions; (D-E) Western blotting and real-time PCR demonstrate that like a Smad3 inhibitor SIS3, pre-treatment with quercetin (64μM) for 24hr is able to inhibit SARS-CoV-2 N protein induced upregulation of p16 and cyclin D1 downregulation in HK-2 cells under high AGE (50µg/ml) conditions; (F) Flowcytometry analysis reveals that pretreated with quercetin (64μM) for 24hr is able to inhibit SARS-CoV-2 N protein induced cell cycle arrest at the G1 phase while increasing the cell progression into the S-phase in HK-2 cells under high AGE (50µg/ml) conditions. Data are presented as mean ± SEM for at least three independent experiments
Jansen, Reimer, Nagai, Varghese, Overheul et al., SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids, Cell Stem Cell
Kang, Jin, Jiang, Zhang, Zhang et al., Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review, Chin Med
Khan, Zeb, Ahsan, Ahmed, Ali et al., SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study, Arch Microbiol
Lai, Tang, Huang, Tang, Xu et al., C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E, Kidney Int
Lan, Mu, Nikolic-Paterson, Atkins, A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens, J Histochem Cytochem
Larsson, Frithiof, Hultstrom, Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients, Cytokine
Lee, Wolstein, Pudasaini, Plotkin, INK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemiareperfusion injury, Am J Physiol Renal Physiol
Legrand, Bell, Forni, Joannidis, Koyner et al., Pathophysiology of COVID-19-associated acute kidney injury, Nat Rev Nephrol
Li, Deng, Guo, Yan, Lu et al., Effective dose/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: A systematic review and meta-analysis of rodent data, Phytomedicine
Lu, Wu, Liu, Ruan, Zhang et al., Quercetin ameliorates kidney injury and fibrosis by modulating M1/M2 macrophage polarization, Biochem Pharmacol
Luo, Bao, Weng, Bai, Feng et al., The protective effect of quercetin on macrophage pyroptosis via TLR2/Myd88/NF-κB and ROS/AMPK pathway, Life Sci
Lyu, Fan, Xiao, Wang, Xu et al., Traditional Chinese medicine in COVID-19, Acta Pharm Sin B
Mangalmurti, Hunter, Cytokine Storms: Understanding COVID-19, Immunity
Menez, Moledina, Thiessen-Philbrook, Wilson, Obeid et al., Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19, Am J Kidney Dis
Munafo, Donati, Brindani, Ottonello, Armirotti et al., Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase, Sci Rep
Nadim, Forni, Mehta, Connor, Jr et al., COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup, Nat Rev Nephrol
Ouyang, Gong, Zhu, Gong, Association of acute kidney injury with the severity and mortality of SARS-CoV-2 infection: A meta-analysis, Am J Emerg Med
Pan, Fang, Zhang, Pan, Liu et al., Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor, Comput Struct Biotechnol J
Pan, Shen, Yu, Ge, Chen et al., SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation, Nat Commun
Price, Safirstein, Megyesi, The cell cycle and acute kidney injury, Kidney Int
Puelles, Lutgehetmann, Lindenmeyer, Sperhake, Wong et al., Multiorgan and Renal Tropism of SARS-CoV-2, N Engl J Med
Saakre, Mathew, Ravisankar, Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2, Beni Suef Univ J Basic Appl Sci
Saeedi-Boroujeni, Mahmoudian-Sani, Anti-inflammatory potential of Quercetin in COVID-19 treatment, J Inflamm (Lond)
Su, Yang, Wan, Yi, Tang et al., Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China, Kidney Int
Tan, Wang, Deng, Zhong, Yan et al., Quercetin protects against cisplatin-induced acute kidney injury by inhibiting Mincle/Syk/NF-κB signaling maintained macrophage inflammation, Phytother Res
Tang, Li, Zhang, Li, Li et al., Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats, Sci Rep
Ueda, Tominaga, Ochi, Sakurai, Nishimura et al., TGF-β1 is involved in senescence-related pathways in glomerular endothelial cells via p16 translocation and p21 induction, Sci Rep
V'kovski, Kratzel, Steiner, Stalder, Thiel, Coronavirus biology and replication: implications for SARS-CoV-2, Nat Rev Microbiol
Vogel, Mustroph, Staudner, Leininger, Hubauer et al., Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19, J Nephrol
Wang, Chen, Hu, Pan, Liang et al., SARS-CoV-2 N Protein Induces Acute Kidney Injury via Smad3-Dependent G1 Cell Cycle Arrest Mechanism, Adv Sci (Weinh)
Wang, Chen, Yu, Lan, Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation, Int J Biol
Witkowski, Tizian, Ferreira-Gomes, Niemeyer, Jones et al., Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells, Nature
Wu, Ma, Cai, Zhuang, Zhao et al., RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation, Signal Transduct Target Ther
Wu, Zhao, Yu, Chen, Wang et al., A new coronavirus associated with human respiratory disease in China, Nature
Yang, Islam, Wang, Li, Chen, Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective, Int J Biol Sci
Yang, Rao, Structural biology of SARS-CoV-2 and implications for therapeutic development, Nat Rev Microbiol
Yang, Xie, Tu, Fu, Xu et al., The signal pathways and treatment of cytokine storm in COVID-19, Signal Transduct Target Ther
Zhao, Nicholls, Chen, Severe acute respiratory syndromeassociated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling, J Biol Chem
Zheng, Sun, Yu, Shi, Zhu et al., Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus, Pathogens
Zheng, Zhao, Yang, Acute Kidney Injury in COVID-19: The Chinese Experience, Semin Nephrol
Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet
{ 'indexed': { 'date-parts': [[2022, 12, 13]], 'date-time': '2022-12-13T05:58:33Z', 'timestamp': 1670911113429}, 'reference-count': 0, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 12, 1]], 'date-time': '2022-12-01T00:00:00Z', 'timestamp': 1669852800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': ['cell.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 12]]}, 'DOI': '10.1016/j.ymthe.2022.12.002', 'type': 'journal-article', 'created': { 'date-parts': [[2022, 12, 12]], 'date-time': '2022-12-12T16:51:44Z', 'timestamp': 1670863904000}, 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking ' 'Smad3-dependent G1 cell cycle arrest', 'prefix': '10.1016', 'author': [ {'given': 'Wenjing', 'family': 'Wu', 'sequence': 'first', 'affiliation': []}, {'given': 'Wenbiao', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Liying', 'family': 'Liang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Junzhe', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Biao', 'family': 'Wei', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiao-Ru', 'family': 'Huang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaoqin', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xueqing', 'family': 'Yu', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4283-9755', 'authenticated-orcid': False, 'given': 'Hui-Yao', 'family': 'Lan', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'container-title': 'Molecular Therapy', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1525001622007067?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1525001622007067?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 12, 12]], 'date-time': '2022-12-12T16:51:45Z', 'timestamp': 1670863905000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1525001622007067'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 12]]}, 'references-count': 0, 'alternative-id': ['S1525001622007067'], 'URL': 'http://dx.doi.org/10.1016/j.ymthe.2022.12.002', 'relation': {}, 'ISSN': ['1525-0016'], 'subject': ['Drug Discovery', 'Pharmacology', 'Genetics', 'Molecular Biology', 'Molecular Medicine'], 'container-title-short': 'Molecular Therapy', 'published': {'date-parts': [[2022, 12]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney ' 'injury by blocking Smad3-dependent G1 cell cycle arrest', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Molecular Therapy', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ymthe.2022.12.002', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2022 The American Society of Gene and Cell Therapy.', 'name': 'copyright', 'label': 'Copyright'}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit